Heterogeneity of Outcomes Reporting in Trials Evaluating Traditional Chinese Medicine Breast Massage for Stasis Acute Mastitis: A Methodological Review / 中国医学科学杂志(英文版)

Objective To systematically analyze the current status of outcomes reporting in clinical trials on treating stasis acute mastitis with Traditional Chinese Medicine breast massage.Methods We searched CNKI, Wanfang, VIP, SinoMed, PubMed, Web of Science, Embase, Cochrane library, JBI, CINAHL, PsycINFO, Clinical Trials Registry Platform portal, Clinical Trials Registry, Australian New Zealand Clinical Trials Registry, Center Watch Registry from inception to May 15, 2022 to find randomized controlled trials, non-randomized controlled trials, case series and cohort studies which reported the outcomes of stasis acute mastitis managed with Traditional Chinese Medicine breast massage, with search terms of mastitis, acute mastitis, lactation mastitis, puerperal mastitis, breast problem, breast engorgement, milk stasis, blocked ducked, breast pain, breast massage, and acupoint massage. Outcomes and the measurement schemes (measurement methods, timing of assessing outcome, frequency of assessing outcome, measurers) were extracted from the included studies. We used the Management of Otitis Media with Effusion in Children with Cleft Palate (MOMENT) to assess the quality of each study, then categorized outcomes derived from the included studies into different domains according to the Outcome Measures in Rheumatology Arthritis Clinic Trials (OMERACT) Filter 2.1 framework.Results We identified 85 clinical trials, in which 54 different outcomes were reported. A total of 81.2% (69/85) of studies were assessed as medium quality with a mean score of 2.6, and 18.8% (16/85) as low quality with a mean score of 0.9. These outcomes were organized in three core areas. Lump size (89.4%, 76/85) was the most frequently reported outcome, followed by breast pain (69.4%, 59/85) and milk excretion (68.2%, 58/85). Five methods were used to assess lump size and four methods to assess breast pain.Conclusions The outcomes reported in clinical trials regarding stasis acute mastitis treated by Traditional Chinese Medicine breast massage are heterogeneous. Developing a core outcome set to achieve consistent standards for reporting outcomes and modalities for validation of the outcomes is clearly warranted.

The Effectiveness of Herbal Medicines on Cyclic Mastalgia: A Systematic Review on Meta-analysis / A eficácia dos medicamentos fitoterápicos na mastalgia cíclica: Uma revisão sistemática em metanálise

Abstract Objective Different drugs are used to treat mastalgia, such as danazol and bromocriptine, and both are associated with side effects, due to which most of women and healthcare providers are interested in herbal medicines. Therefore we aim to study the effectiveness of phytoestrogens on the severity of cyclic mastalgia. Methods To carry out the present study, English electronic resources such as the Cochrane Library, ISI Web of Science, Scopus, and PubMed were used systematically and with no time limitation up to February 10, 2020. Results In total, 20 studies were included in the present meta-analysis. The results of the meta-analysis showed that herbal medicines versus the control group (standard mean difference [SMD] = - 0.585; 95% confidence interval [CI]: - 0.728-- 0.44; heterogeneity; p = 0.02; I2 = 42%), herbal medicines versus the B group (SMD = - 0.59; 95%CI: - 0.75-- 0.44; heterogeneity; p = 0.03; I2 = 42%), and its subgroups, such as phytoestrogen (SMD = - 0.691; 95%CI: - 0.82-- 0.55; heterogeneity; p = 0.669; I2 = 0%), Vitex-agnus-castus (SMD = - 0.642; 95%CI: - 0.84-- 0.44; p < 0.001; p = 203; I2 = 32%), flaxseed (SMD = - 0.63; 95%CI: - 0.901-- 0.367; p = 0.871; I2 = 0%), and evening primrose (SMD= - 0.485; 95%CI:- 0.84-- 0.12; p = 0.008; heterogeneity; p = 0.06; I2 = 56%] may have effective and helpful effects on improving cyclic breast mastalgia. Also, chamomile, isoflavone, cinnamon, and nigella sativa significantly reduced mastalgia symptoms. Conclusion Herbal medicines and their subgroups may have effective and helpful effects on improving cyclic breast mastalgia. The findings of our meta-analysis must be done cautiously because low methodological quality in some evaluated studies of this systematic review.

Resumo Objetivo Diferentes drogas são utilizadas para tratar a mastalgia, como danazol e bromocriptina, e ambas estão associadas a efeitos colaterais, devido aos quais a maioria das mulheres e dos profissionais de saúde está interessada em medicamentos fitoterápicos. Portanto, nosso objetivo no presente estudo é estudar a eficácia dos fitoestrogênios na gravidade da mastalgia cíclica. Métodos Para a realização do presente estudo, foram utilizados recursos eletrônicos em inglês como a Cochrane Library, ISI Web of Science, Scopus e PubMed, de forma sistemática e sem limitação de tempo até 10 de fevereiro de 2020. Resultados No total, 20 estudos foram incluídos na presente metanálise. Os resultados da metanálise mostraram que fitoterápicos versus grupo controle (SMD = - 0,585; intervalo de confiança (IC) 95%: - 0,728-- 0,44; heterogeneidade; p = 0,02; I2 = 42%), fitoterápicos versus grupo B (SMD = - 0,59; IC95%: - 0,75-- 0,44; heterogeneidade; p = 0,03; I2 = 42%) e seus subgrupos, como fitoestrogênios (SMD = - 0,691; IC95%: - 0,82-- 0,55; heterogeneidade; p = 0,669; I2 = 0%), Vitex-agnus-castus (SMD = - 0,642; IC95%: - 0,84-- 0,44; p < 0,001; p = 203; I2 = 32%), linhaça (SMD = - 0,63; IC95%: - 0,901-- 0,367; p = 0,871; I2 = 0%) e prímula (SMD = - 0,485; IC95%: - 0,84-- 0,12; p = 0,008; heterogeneidade; p = 0,06; I2 = 56%) podem ter efeitos eficazes e úteis na melhora da mastalgia cíclica da mama. Além disso, camomila, isoflavona, canela e Nigella sativa reduziram significativamente a mastalgia. Conclusão Os medicamentos fitoterápicos e seus subgrupos podem ter efeitos eficazes e úteis na melhora da mastalgia mamária cíclica. Os achados do presente estudo devem ser explantados com atenção devido ao pequeno número de estudos existentes sobre o tema, a maioria dos quais com um tamanho de amostra pequeno.

A aplicação da laserterapia no tratamento de traumas mamilares: revisão de literatura / Application of laser therapy in the treatment of nipple traumas: a literature review / Aplicación de laserterapia en el tratamiento del traumatismo del pezón: revisión de literatura

OBJETIVO: Identificar na literatura científica a aplicação da laserterapia de baixa intensidade no tratamento de traumas mamilares em puérperas. MÉTODO: Trata-se de uma revisão integrativa da literatura. O levantamento das publicações ocorreu no período de setembro a novembro de 2020, utilizando os descritores "low-level light therapy" e "laser therapy", além da palavra-chave: "nipple trauma", nas bases de dados da PubMed, EMBASE, CINAHL, Scopuse Web of Science.Após a leitura e análise dos artigos, 3 artigos foram selecionados para a amostra final. RESULTADOS: Os dados analisados compuseram dois eixos temáticos denominados: "Uso da laserterapia no alívio da dor mamilar" e "Uso da laserterapia na cicatrização de fissuras mamilares". CONCLUSÃO: A aplicação da laserterapia resultou na diminuição da dor e boa regeneração tecidual mamilar, contribuindo para manutenção do aleitamento materno.

OBJECTIVE: To identify in the scientific literature the application of low-level laser therapy in the treatment of nipple traumas in puerperal women. METHOD: This is an integrative literature review.The survey of publications took place from September to November2020, using the descriptors "low-level light therapy" and "laser therapy", in addition to the keyword"nipple trauma", in the PubMed, EMBASE, CINAHL, Scopus and Web of Science databases.After reading and analyzing the articles, 3 were selected for the finalsample. RESULTS: The analyzed data composed two thematic axes, namely: "The use of laser therapy for nipple pain relief" and "The use of laser therapy in the healing of nipple fissures". CONCLUSION: The application of laser therapy resulted in pain reduction and in good nipple tissue regeneration, contributing to the maintenance of breastfeeding.

OBJETIVO: Identificar en la literatura científica la aplicación de laserterapia de baja intensidad en el tratamiento del traumatismo del pezón en mujeres posparto. MÉTODO: Se trata de una revisión integradora de la literatura. El levantamiento de publicaciones se realizó de septiembre a noviembre de 2020, utilizando los descriptores "low-level light therapy" y "laser therapy", además de la palabra clave: "nipple trauma", en las bases de datos de PubMed, EMBASE, CINAHL, Scopus y Web of Science. Después de leer y analizar los artículos, se seleccionaron 3 artículos para la muestra final. RESULTADOS: Los datos analizados comprendieron dos ejes temáticos denominados: "Uso de laserterapia para aliviar el dolor del pezón" y "Uso de laserterapia para la cicatrización de las grietas del pezón". CONCLUSIÓN: La aplicación de laserterapia dio como resultado una disminución del dolor y una buena regeneración del tejido del pezón, contribuyendo al mantenimiento de la lactancia.

Efeitos adversos associados a uso de contraceptivos orais em discentes / Adverse effects associated with students' use of oral contraceptives

Objetivos: Investigar o número de mulheres, as causas que levam a fazer o uso e descrever os efeitos adversos mais comuns associados ao uso de contraceptivos orais de forma contínua. Métodos: Trata-se de estudo observacional, transversal ou de prevalência e quantitativo. A pesquisa teve população de 832 alunas do curso de Direito dos turnos matutino, vespertino e noturno, no período de agosto a setembro, tendo como amostra 248 participantes para esse estudo. O questionário versou sobre o uso de anticoncepcionais, o perfil das usuárias e os possíveis efeitos adversos observados ao longo do uso. Resultados: A prevalência de uso dos contraceptivos orais foi de 42,3%, justificada principalmente pelo desejo de evitar a concepção (42,9%), regular os níveis hormonais (25,7%) e tratar acne (15,2%). Cerca de 63,8% relataram que já sentiram algum desconforto associado ao uso destes medicamentos, sendo os mais frequentes aumento de peso corporal (32,4%), alterações de humor (24,3%), dor nas mamas (13,5%), cefaleia (4,1%), dor abdominal (2,7%). Conclusão: A prevalência de efeitos adversos decorrentes do uso contínuo de contraceptivos orais é alta, evidenciando-se a necessidade de conscientizar as usuárias a buscarem profissionais habilitados, para que elas façam uso do anticoncepcional mais adequado, minimizando o desconforto advindo dos efeitos adversos.

Objectives: To investigate the number of women, the causes that lead to making use, and to describe the most common adverse effects associated with oral contraceptive continuous use. Methods: This is an observational, cross-sectional, or prevalence and quantitative study. The research had a population of 832 students of the law course of the morning, afternoon and evening shifts, from August to September, with a sample of 248 participants for this study. The questionnaire was about contraceptive use, users' profile, and possible adverse effects observed during use. Results: The prevalence of oral contraceptive use was 42.3%, mainly explained by the desire to avoid conception (42.9%), regulate hormone levels (25.7%), and to treat acne (15.2%). About 63.8% reported already having some discomfort associated with the use of these medications, with the most frequent being body weight gain (32.4%), mood swings (24.3%), breast pain (13.5%), headache (4.1%), abdominal pain (2.7%). Conclusion: The prevalence of adverse effects resulting from the continued use of oral contraceptives is high, so there is a need to guide users to seek qualified professionals so that they make use of the most appropriate contraceptive, minimizing the discomfort arising from adverse effects.

Efectos adversos del implante anticonceptivo subdérmico en adolescentes / Adverse effects of the subdermal contraceptive implant in adolescents

Introducción: Los anticonceptivos subdérmicos deben ser seguros, con efectos colaterales mínimos, reversibles y de larga duración, sin embargo, se ha observado que ocasionan efectos adversos, fundamentalmente en los primeros meses de su uso. Objetivos: Describir efectos adversos, junto a antecedentes personales en adolescentes a quienes se realizó implante anticonceptivo subdérmico. Métodos: Se realizó un estudio descriptivo en 120 adolescentes a las que se les colocó implante subdérmico como método anticonceptivo. Fueron estudiadas las variables efectos adversos, edad y antecedente obstétrico. Resultados: El 36,6 por ciento de las pacientes tenía antecedentes de abortos provocados, y el 5 por ciento era menor de 15 años. Los efectos adversos más frecuentes fueron el aumento de peso (23,3 por ciento a los 6 meses y 21,6 por ciento al año), la cefalea (18,3 por ciento a los 6 meses y 8,3 por ciento al año) y la mastalgia (12,5 por ciento a los 6 meses y 15 por ciento al año). En el patrón de sangrado, se presentaron, sangrado infrecuente (36 por ciento a los 6 meses y 43,3 por ciento al año) y amenorrea (27,5 por ciento a los 6 meses y 35 por ciento al año). Conclusiones: Más de un tercio de las pacientes tenían abortos previos; los efectos adversos más frecuentes fueron: aumento de peso, cefalea y mastalgia, tanto a los 6 meses como al año y en el patrón de sangrado, el sangrado infrecuente y la amenorrea(AU)

Introduction: Subdermal contraceptives must be safe, with minimal side effects, reversible and long lasting, however, it has been observed that they cause adverse effects, mainly in the first months of its use. Objectives: To describe adverse effects, together with personal history in adolescents who underwent a subdermal contraceptive implant. Methods: A descriptive study was conducted in 120 adolescents who were placed as a subdermal implant as a contraceptive method. The variables adverse effects, age and obstetric history were studied. Results: 36.6 percent of the patients had a history of induced abortions, and 5 percent were younger than 15 years. The most frequent adverse effects were weight gain (23.3 percent at 6 months and 21.6 percent per year), headache (18.3 percent at 6 months and 8.3 percent per year) and mastalgia (12.5 percent at 6 months and 15 percent at year). In the pattern of bleeding, infrequent bleeding occurred (36 percent at 6 months and 43.3 percent per year) and amenorrhea (27.5 percent at 6 months and 35 percent per year). Conclusions: More than a third of the patients had previous abortions; The most frequent adverse effects were: weight gain, headache and mastalgia, both at 6 months and 1 year and in the pattern of bleeding, infrequent bleeding and amenorrhea(AU)

Evening Primrose (Oenothera biennis) Oil in Management of Female Ailments

Oenothera biennis with the common name of “evening primrose” is containing a valuable fixed oil with commercial name of EPO. Evening primrose oil has two types of omega-6-fatty acid including linoleic acid (60%–80%) and γ-linoleic acid (8%–14%). Essential fatty acids are considered as essential compounds for body health, especially among women. The aim of this study was to evaluate the efficacy of evening primrose oil in the management of women ailments. The document was prepared by investigation in scientific articles of electronic resources (Google Scholar, PubMed, Science Direct, Wiley, Scopus, and Springer) by keywords of evening primrose oil and women. The results of our investigations showed that evening primrose oil has been the subject of several clinical studies, including premenstrual syndrome (PMS), hot flash, mastalgia, fibroadenomas, gestational diabetes, cervical ripening, and dilation. The major clinical studies are focused on mastalgia, followed by PMS. The results of studies confirmed the evening primrose oil's efficacy in women health, but the immediate response should not be expected from it, therefore, it should be regularly used up to 4 or 6 months.

A Systematic Review of Breast Care for Postpartum Mothers / 여성건강간호학회지

PURPOSE: The purpose of this study was to identify nursing interventions for the postpartum breast care of mothers and determine the effectiveness of interventions for breast pain and engorgement by systematic review. METHODS: Eight national and international databases were reviewed to retrieve and collect randomized controlled trial and controlled clinical trial literature published up to March 2015. Two reviewers independently selected the studies and performed data abstraction and validation. The risk of bias was assessed using Cochrane criteria. A meta-analysis of the studies was performed to analyze the data. RESULTS: The meta-analysis showed that breast massage, along with routine breast care, resulted in a 3.52-point reduction in pain on a 10-point visual analogue scale. Meta-analysis of therapy with cold cabbage leaves and routine breast care showed a pain reduction of 0.54 points. Meta-analysis of cold cabbage leaf application in the experimental group versus cold compress therapy in the comparison group showed a pain reduction of 0.44 points. Meta-analysis of cold cabbage leaf application and routine breast care showed an engorgement reduction of 0.67 points. CONCLUSION: The results of the analysis of 12 articles showed that hot and cold compresses, breast massage, and cabbage application were effective for postpartum breast pain and engorgement.

Complications of polyacrylamide hydrogel injection for breast augmentation: A case report and literature review

Polyacrylamide hydrogel (PAAG) was developed in the 1980s as an injectable filler for breast augmentation and tissue contour improvement, but its potential risk for oncogenesis and the frequent occurrence of chronic complications after injections led to the prohibition of its further use as an injectable material. Although breast augmentation with PAAG injections was mostly performed in China and Eastern Europe, the migration of patients and long-term complications of the procedure made it a global concern. Herein, we describe the case of a 49-year-old woman who immigrated to Korea after undergoing breast augmentation via PAAG injection in China, and complained of persistent mastodynia and retraction of both breasts. Surgical treatment was undertaken, along with removal of the PAAG and total capsulectomy of the fibrous capsule containing the gel through an inframammary fold incision. We share our experience of diagnosing and treating this case, and present a literature review.

Calidad de vida según el estadio del cáncer de seno en mujeres: análisis desde el fact-b y sf-36 / Quality of life according to the stage of breast cancer in women: analysis from the fact-b and sf-36

Resumen El cáncer se clasifica según criterios histológicos en estadios (0 o in situ, I, II, III y IV), los cuales se asocian a las tasas de sobrevida. El cáncer de mama afecta la calidad de vida de las pacientes. A partir de un estudio relacional, no experimental en una muestra no probabilística de 39 mujeres (M = 56.2, DE = 13.4) diagnosticadas con cáncer de mama, se analiza la calidad de vida y posibles diferencias según el estadio de cáncer, y se relacionan las medidas del SF-36 y el FACT-B. Los resultados describen que en estadios avanzados, los puntajes de calidad de vida son bajos en comparación a los iniciales; sin embargo, las diferencias no alcanzan la significancia estadística. Los instrumentos se relacionaron positivamente entre sí. Se concluye que la calidad de vida no difiere según los estadios oncológicos y que ambos instrumentos correlacionaron positiva y significativamente. Estos resultados alientan a nuevos trabajos en esta línea.

Abstract Cancer is classified in stages (0 or in situ, I, II, III and IV) according to histological criteria, which are associated with survival rates. Breast cancer affects the quality of life of patients. In this correlational and not experimental study, with a non probabilistic sample of 39 women diagnosed with breast cancer (M = 56.2, SD = 13.4), we analyzed the quality of life and its possible differences according to the stage of cancer; moreover, we correlated the SF-36 and FACT-B measures. The results show that the quality of life is lower in advanced stages; however, the differences are not statistically significant; and that the instruments are positively correlated. We conclude that the quality of life does not varies according to the stage of breast cancer, and both instruments correlated positive and significantly. These findings encourage further work in this area.

Prevalencia de patología maligna de seno en mujeres mayores de 14 años que consultaron por masa sólida palpable / Prevalence of breast malignancy in women older than forteen years who consulted for solid palpable mass

Objetivo Establecer la prevalencia de la patología maligna en pacientes con masa sólida palpable, sin diagnóstico previo de cáncer de seno en dos hospitales de Bogotá, Colombia. Materiales y métodos Estudio descriptivo retrospectivo entre marzo de 2010 y febrero de 2013 en los hospitales de San José e Infantil Universitario de San José, Bogotá D. C., Colombia. Se incluyeron mujeres mayores de 14 años que consultaron por masa sólida palpable sin diagnóstico previo de cáncer de seno, corroborada por examen físico; no se consideró ningún criterio de exclusión. Los datos se recolectaron de las historias clínicas y se llevaron a un formato creado por los investigadores. El programa estadístico utilizado fue Stata 13. Resultados Se confirmó la masa en 342 pacientes por examen clínico, en 307 pacientes con resultado de biopsia. La prevalencia de la patología maligna fue 12,2% y benigna 71,66%. Discusión La prevalencia de patología maligna por masa palpable fue menor que los datos reportados a nivel mundial, siendo el tumor más frecuente el carcinoma ductal infiltrante en un 87%, carcinoma lobulillar infiltrante en 6,4%), con estadio clínico IIA y BI-RADS 4 A (ecografía) y BI-RADS 4B (mamografía).

Objective To determine the prevalence rate of malignancy in patients with no prior breast cancer diagnosis who consulted for a solid palpable mass in two hospitals in Bogotá, Colombia. Materials and methods A descriptive retrospective study conducted between March 2010 and February 2013 at San José and Infantil Universitario de San José hospitals in Bogotá D. C., Colombia. Women 14 years or older with no prior breast cancer diagnosis who consulted for a palpable solid mass, confirmed by physical exam, were included. No exclusion criteria were considered. Data was collected from the clinical records and included in a format created by the researchers. Stata 13 was used for data analysis. Results The mass was confirmed by physical exam in 342 patients and by a biopsy in 307 patients. The prevalence rate for malignancy was 12.2% and for benign masses 71.66%. Discussion Our prevalence of breast cancer associated with a palpable mass was less than worldwide reported prevalence. The most frequent malignancy was invasive ductal carcinoma in 87% and invasive lobular carcinoma in 6.4% in stage IIA and BI-RADS 4A ultrasound category and BI-RADS 4B mammogram category.

Efficacy and safety of drospirenone 2 mg/17β-estradiol 1 mg hormone therapy in Korean postmenopausal women

This regulatory post-marketing surveillance study aimed to evaluate the therapeutic efficacy and safety of drospirenone (DRSP) 2 mg/estradiol (E₂) 1 mg tablet in Korean postmenopausal women. A total of 4,149 patients were enrolled and the study was conducted at 207 clinical research centers. The patients' source data was collected between November 2006 and November 2012. More than 85% of patients experienced improvement of menopausal symptoms. The most frequently reported adverse events were vaginal bleeding and breast pain; most of the women suffering from these symptoms fully recovered. The incidence of adverse event was higher in patients of younger age (20 to 39 years), in patients with concomitant diseases, previous hormone replacement therapy in medical history, those treated with DRSP 2 mg/E₂ 1 mg for shorter duration (3 years or less) and in patients using concomitant medication. In conclusion, the results from this large post-marketing surveillance study confirm the efficacy and safety of DRSP 2 mg/E₂ 1 mg tablet in Korean postmenopausal women.

Immediate Implant Reconstruction after Eliminating Polyacrylamide Hydrogel (Amazingel) in Complicated Breasts

Many injection materials have been used in cosmetic surgery for soft-tissue contour correction or breast augmentation. In China, Amazingel injection mammaplasty had been used widely because the procedure was non-invasive and easy to perform. But, numerous complications have been reported after injection of Amazingel composed of polyacrylamide gel such as breast pain, hardening, deformity, lump, gel migration, etc. In this article, we report a case of a 37-year-old Chinese female who complained of breast discomfort and deformity after Amazingel injection. We safely eliminated Amazingel and reconstructed the breasts with silicone implants. We could achieve aesthetically tolerable results.

A Case of Gynecomastia Induced by Use of Doxazosin / 대한내과학회지

Doxazosin is an adrenergic alpha-1 receptor antagonist used to treat lower urinary tract symptoms that are common in prostatic hyperplasia. To our knowledge, few cases of gynecomastia and mastodynia, as a complication of adrenergic alpha-1 receptor antagonist, have been reported to date; no cases have been reported in Korea. We describe a case involving a 78-year-old man treated for prostatic hyperplasia with 13 months of doxazosin. He complained about unilateral gynecomstia and mastodynia. Five months after the discontinuation of doxazosin, the gynecomastia was significantly improved. This is the first reported case of gynecomastia and mastodynia associated with doxazosin use in Korea.

Can mastalgia be another somatic symptom in fibromyalgia syndrome?

OBJECTIVE: The purposes of this study were to determine the coexistence of mastalgia and fibromyalgia, to investigate the effects of this combination on pain patterns, and to discuss the status of breast pain in the diagnostic algorithm of fibromyalgia syndrome. METHODS: Sixty-one female patients reporting breast pain during the last three months and 53 female patients diagnosed with fibromyalgia syndrome were enrolled in this study. The Breast Pain Questionnaire was administered to all participants in the mastalgia group and to those in the fibromyalgia syndrome group who had experienced mastalgia during the past three months. The patients in the fibromyalgia syndrome group were evaluated using the 2010 preliminary American College of Rheumatology classification criteria. All of the patients in the mastalgia group were evaluated for the diagnosis of fibromyalgia syndrome by a single physiatrist. The coexistence and pain patterns of mastalgia and fibromyalgia were assessed statistically. RESULTS: Approximately half of the patients with fibromyalgia syndrome (47.2%) reported having mastalgia at the time of admission and 37.7% of the patients with mastalgia met the diagnostic criteria for fibromyalgia syndrome. The patients with mastalgia in the fibromyalgia syndrome group had significantly higher total breast pain scores compared with the women in the mastalgia group. In addition, the patients with fibromyalgia syndrome in the mastalgia group had significantly higher Widespread Pain Index and Symptom Severity Scale scores than the patients with fibromyalgia syndrome. CONCLUSIONS: We suggest that mastalgia can be an aspect of the central sensitivity syndrome and can be added to the somatic symptoms of fibromyalgia.

Politelia: presentación de un caso clínico, Hospital Escuela Universitario / Polythelia: a clinical case, Hospital Escuela Universitario

Antecedentes: La presencia de pezones supernumerarios sin asociarse a otras estructuras anatómicas de la mama es la malformación mas frecuente del tejido mamario accesorio, denominada politelia. La mayoría ocurren de forma esporádica, aunque se han descrito distintos patrones de herencia. Normalmente, se encuentran siguiendo el trayecto de las lineas mamarias, que van desde las axilas hasta la región inguinal. Sin embargo, encontrar politelia ya sea bilaterales, familiares, lejos de las lineas mamarias, sin tejido mamario subyacente o sin asociación a malformaciones congénitas es un hecho excepcionalmente descrito en la literatura. Caso clínico: Presentamos el caso de paciente femenina de 24 años que acude por presentar mastodinia, y que a la exploración de mamas se encuentra pezón supernumerario en region torácica infrareolar derecha; la paciente refería presentarlo desde el nacimiento, con leve desarrollo durante la pubertad. Niega episodios de secreción o cambios durante los ciclos menstruales, afirma antecedentes familiares de politelia en su madre y abuela. No se encontraron mas alteraciones. Conclusión: Este hallazgo, es de importancia clínica ya que esta patología se asocia a neoplasias y malformaciones genéticas por lo que es conveniente conocer el tema...(AU)

Bilateral Thoracodorsal Neuromas: A Cause of Persistent Breast Pain after Bilateral Latissimus Dorsi Breast Reconstruction

No abstract available.

Triple assessment in the diagnosis of carcinoma breast: mammography along with clinical symptomatology

To determine the clinical symptoms and marnrnographic findings in patients of carcinoma breast. Validation study. Armed Forces Institute of Radiology and Imaging Rawalpindi, from January 2011 to Dec 2011. Women of > 30 years of age including premenopausal and postmenopausal with positive findings on histopathology were included in the study. Pregnant women, breast-feeding women, women younger than 30 years old [in whom only sonography was performed] were excluded from the study. Total 57 female patients were included in the study through non-probability consecutive sampling. Mean age of the patients was 52.8 years [SD = 10.3]. Age range of the patients was between 32-72 years. Maximum patients were in the age group of 40 - 50 years. A total of 42.1% patients reported with complaint of lump and mastalgia while 29.8% with lump alone. As far as mammographic findings are concerned speculated mass with axillary lymphadenopathy was the major finding. Histopathological results showed that most common malignant mass was invasive ductal carcinoma [89.5%]. Mammography is the mainstay for evaluation of breast cancer but only patients with the complaints of lump and mastalgia should be evaluated through mammography to avoid unnecessary evaluation

Alterações funcionais benignas da mama / Benign functional alteration of the breast

A alteração funcional benigna da mama está intimamente relacionada à ansiedade e ao medo do câncer de mama. Acomete cerca de 70% das mulheres, 54% de mamas normais à autópsia, 34% de biópsias mamária e 40% de todos os cânceres de mama. Tem sido observada maior incidência nas pacientes de alto poder econômico. O diagnóstico é basicamente clínico e está relacionado à história de dor mamária pré-menstrual de caráter progressivo, ocupando todo o ciclo, além da presença de vários "nódulos". Ocorre na idade reprodutiva com pico entre mulheres de 30 a 40 anos. O quadro clínico passa obrigatoriamente por dor e nodularidade. O diagnóstico radiológico se restringe à mamografia e ao ultrassom sem alterações patológicas. A confirmação diagnóstica é dada pelo estudo anatomopatológico, através de punção aspirativa por agulha fina, trocarte e biópsia cirúrgica. A principal conduta terapêutica é afastar a causa oncológica como responsável pela mastalgia, portanto o exame físico das mamas, adicionado aos exames subsidiários, é obrigatório. Com a exclusão de processo neoplásico, 60% a 80% das pacientes têm remissão espontânea da dor. A presença de nodularidade deve ser tratada de acordo com o resultado anatomopatológico. A indicação de retirada da área somente ocorre na vigência de diagnóstico duvidoso ou suspeito e, até mesmo, nos casos de refratariedade ao tratamento clínico. O tratamento medicamentoso se baseia no emprego de várias drogas, tais como progesterona, antiprolactinas, agentes antigonadotropinas, medicamentos competidores com os receptores hormonais para estrogênio, uso de análogo de GnRH (goserelina), ácido gamalinoleico, restrição de metilxantinas, vitaminas E e A, complexo B, diuréticos e anti-inflamatórios...

Aislamiento de Staphylococcus aureus meticilino resistente en abscesos de mama en una Maternidad Pública / Methicillin-resistant Staphylococcus aureus (MRSA) isolation in breast abscesses in a Public Maternity

La mastitis y los abscesos de mama representan un factor de riesgo para el abandono de la lactancia. Se incluyen dentro de las infecciones de piel y partes blandas y comparten los cambios epidemiológicos que llevan a replantear el tratamiento empírico inicial. Se estudiaron 137 casos de abscesos de mama desde enero de 2007 a diciembre de 2011. Se analizó incidencia, días postparto, factores de riesgo, datos microbiológicos y tratamiento antibiótico. Desde 2007a 2011 se observó un constante aumento de la incidencia de casos: 0.19 vs. 0.84% (p < 0.001). Días postparto de aparición del absceso 41.9 ± 35.8 días (Media ± DE), primiparidad 70.6%. Los factores de riesgo más frecuentemente encontrados fueron grietas del pezón e ingurgitación mamaria (95%). Staphylococcus aureus (SA) fue el responsable de 82.3 a 95.0% de los abscesos según los años; la resistencia a oxacilina de las cepas de SA superó el 60%. Las cepas aisladas de SA meticilino resistentes (SAMR) fueron sensibles a eritromicina clindamicina, gentamicina, rifampicina, ciprofloxacina y trimetroprima-sulfametoxasol en diferentes porcentajes según los años. Requirieron drenaje el 100% de los casos; en 60% el tratamiento empírico inicial fue inadecuado. Continuaron amamantando 90% de las madres. Estos datos enfatizan la necesidad de prevenir los factores de riesgo: grietas del pezón e ingurgitación mamaria. La modificación del tratamiento antibiótico inicial requiere el estudio bacteriológico de las infecciones de piel y partes blandas dado que la prevalencia de SAMR no es uniforme y varía en diferentes poblaciones y ubicaciones geográficas.

Mastitis and breast abscess in lactating women are risk factors for early breastfeeding cessation. This pathology is included in the group of skin and soft tissue infections. A descriptive study was performed with an advanced outlook. As of January 2007 through December 2011 a total of 137 breast abscesses were treated in our institution. We analyzed incidence, parity, postpartum days, risk factors, microbiological isolation and the adequacy of initial antibiotic treatment. In that period we observed a steady and significant increase in breast abscesses. Incidence from 0.19 to 0.84% in lactating women 2007 vs. 2011 p = 0.0001 IC 95% (-0.009; 0.003), 70.6% of them primiparous and a mean interval from delivery to breast abscess of 41.9 ± 35.8 days. The most frequent risk factors were sore nipples and breast engorgement. Staphylococcus aureus was isolated in 82.3 to 95.0%. Methicillin resistance was higher than 60%. These strains were susceptible to erythromycin, clindamycin, gentamicin, rifampicin, ciprofloxacin and trimethoprim-sulfamethoxazol. All the cases were surgically drained; the initial empirical treatment was inadequate in 60% of them, 90% of patients could maintain breast feeding after the procedure. In conclusion: these data emphasize the need to prevent risk factors associated to breast abscesses: sore nipples and breast engorgement. In order to determine the adequate antibiotic treatment, bacteriological studies are required at every collection because SAMR prevalence varies according to diverse populations and geographic location.